National (A) Medicare prescription rates per thousand Part D enrollees and (B) Medicare spending for clozapine gradually decreased for 2015-2020. by Luke R. Cavanah (19022435)

Subjects:

Western blotting for OMP expression using olfactory bulb and olfactory epithelium. by Myeongguk Jeong (16386165)

Subjects:

Olfactory function test graphical summary and results. by Myeongguk Jeong (16386165)

Subjects:

Immunohistochemical staining results for OMP in olfactory bulb. by Myeongguk Jeong (16386165)

Subjects:

The pooled effect of all-cause mortality rate in non-health care workers and health care workers. by Zhuoyang Xia (21354186)

Adverse cardiovascular events by immune checkpoint inhibitor. by Jennifer M. Kwan (3350321)

Subjects:

Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events. by Jennifer M. Kwan (3350321)

Subjects:

Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE. by Jennifer M. Kwan (3350321)

Subjects:

Meta Analysis for Effectiveness of RFX for Primary and Secondary Prevention. by Yangyang Hu (3309009)

Subjects:

Subgroup Meta Analysis for HE Incidence Based on Treatment Duration and Dose. by Yangyang Hu (3309009)

Subjects:

Flowchart of Study Screen and Exclusion Criteria in this Meta-analysis. by Yangyang Hu (3309009)

Subjects:

Table includes all literature and exclusion grounds. by Yangyang Hu (3309009)

Subjects:

Meta Analysis for HE Incidence. by Yangyang Hu (3309009)

Subjects:

Moderate correlation (R² = 0.136 p = .0085) between Medicare prescriptions per 1,000 persons and the percentage of white population among the fifty US states. by Luke R. Cavanah (19022435)

Subjects:

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 ^a indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

Subjects:

Strong correlation (R² = 0.734 p < .0001) between Medicare prescriptions per 1,000 persons and Medicaid prescriptions per 1,000 persons among the fifty US states in 2019... by Luke R. Cavanah (19022435)

Subjects:

Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 ^a indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)

Subjects:

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 ^a indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

Subjects:

Medicare clozapine data analysis. by Luke R. Cavanah (19022435)

Subjects:

Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 ^a indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

Subjects: